AstraZeneca plc (AZN) PT Set at GBX 4,100 by HSBC Holdings plc
HSBC Holdings plc set a GBX 4,100 ($53.39) price target on AstraZeneca plc (LON:AZN) in a research note issued to investors on Tuesday. The firm currently has a sell rating on the biopharmaceutical company’s stock.
Several other brokerages have also recently issued reports on AZN. Shore Capital reaffirmed a hold rating on shares of AstraZeneca plc in a research note on Wednesday, June 21st. Deutsche Bank AG decreased their target price on shares of AstraZeneca plc from GBX 5,700 ($74.23) to GBX 5,300 ($69.02) and set a buy rating for the company in a report on Thursday, August 3rd. Liberum Capital reiterated a buy rating and issued a GBX 5,500 ($71.62) target price on shares of AstraZeneca plc in a report on Monday, June 5th. Credit Suisse Group reiterated a neutral rating and issued a GBX 5,000 ($65.11) target price on shares of AstraZeneca plc in a report on Monday, June 19th. Finally, J P Morgan Chase & Co reiterated a neutral rating on shares of AstraZeneca plc in a report on Thursday, May 11th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have given a buy rating to the stock. The company has a consensus rating of Hold and a consensus price target of GBX 4,932.67 ($64.24).
AstraZeneca plc (LON:AZN) opened at 4384.00 on Tuesday. The firm’s 50-day moving average is GBX 4,929.68 and its 200 day moving average is GBX 4,859.79. AstraZeneca plc has a 12 month low of GBX 3,996.00 and a 12 month high of GBX 5,520.00. The firm’s market capitalization is GBX 55.50 billion.
The company also recently declared a dividend, which will be paid on Monday, September 11th. Stockholders of record on Thursday, August 10th will be given a GBX 68.90 ($0.90) dividend. This represents a dividend yield of 1.35%. The ex-dividend date is Thursday, August 10th.
In other news, insider Nazneen Rahman purchased 39 shares of the company’s stock in a transaction dated Thursday, July 27th. The shares were bought at an average price of GBX 4,370 ($56.91) per share, with a total value of £1,704.30 ($2,219.43).
About AstraZeneca plc
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.
Receive News & Stock Ratings for AstraZeneca plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc and related stocks with our FREE daily email newsletter.